Oxford Vaccine
- World
Oxford vaccine trial continues amid death report
London: The University of Oxford says the late-stage trial of its COVID-19 vaccine in Brazil will continue following reports of a participant’s death. The university said it can’t comment on specific incidents…
- World
Oxford COVID-19 vaccine could be rolled out within six months: Report
London: There is growing hope that a vaccine against coronavirus may be given the green light by health regulators by the end of this year to be rolled out for a vaccination programme…
- India
Covid-19: Phase II trial of Oxford vaccine begins
New Delhi: The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two males, aged 28 and 48, in Pune’s Bharti Vidyapeeth’s…
- Top Stories
Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin today
New Delhi: The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin from Tuesday. The observer-blind,…
- Top Stories
Oxford COVID-19 Vaccine to cost Rs 225 per dose in India
New Delhi; The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for COVID-19 at less than Rs 250 per dose in India. The Pune-based institute would offer up to…
- News
PGI-Chandigarh among 17 trial sites for Oxford vaccine
Chandigarh: The PGI Hospital here is among the 17 trial sites in India for conducting the second and third phases of human clinical trials of Covishield, the potential vaccine developed by Oxford University,…
